These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 30209807

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.
    Lucroy MD, Clauson RM, Suckow MA, El-Tayyeb F, Kalinauskas A.
    BMC Vet Res; 2020 Nov 18; 16(1):447. PubMed ID: 33208160
    [Abstract] [Full Text] [Related]

  • 23. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL, London CA, Portela RA, Nguyen S, Rosenberg MP, Klein MK, Clifford C, Thamm DH, Vail DM, Bergman P, Crawford-Jakubiak M, Henry C, Locke J, Garrett LD.
    BMC Vet Res; 2015 Jun 11; 11():131. PubMed ID: 26062540
    [Abstract] [Full Text] [Related]

  • 24. A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma.
    Teske E, Rutteman GR, Kirpenstein J, Hirschberger J.
    Vet Comp Oncol; 2011 Dec 11; 9(4):283-9. PubMed ID: 22077409
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ, Philibert JC, Siegel S, Clifford CA, Risbon R, Zivin K, Cronin KL.
    J Am Vet Med Assoc; 2008 Jul 01; 233(1):122-8. PubMed ID: 18593321
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993).
    Wood CA, Moore AS, Gliatto JM, Ablin LA, Berg RJ, Rand WM.
    J Am Anim Hosp Assoc; 1998 Jul 01; 34(5):417-21. PubMed ID: 9728473
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.
    Sorenmo KU, Baez JL, Clifford CA, Mauldin E, Overley B, Skorupski K, Bachman R, Samluk M, Shofer F.
    J Vet Intern Med; 2004 Jul 01; 18(2):209-13. PubMed ID: 15058772
    [Abstract] [Full Text] [Related]

  • 39. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
    Burton JH, Powers BE, Biller BJ.
    Vet Comp Oncol; 2014 Sep 01; 12(3):198-204. PubMed ID: 22905712
    [Abstract] [Full Text] [Related]

  • 40. Canine hemangiosarcoma treated with standard chemotherapy and minocycline.
    Sorenmo K, Duda L, Barber L, Cronin K, Sammarco C, Usborne A, Goldschmidt M, Shofer F.
    J Vet Intern Med; 2000 Sep 01; 14(4):395-8. PubMed ID: 10935889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.